Aim The aim of this study was to characterize an alternative treatment for dilated cardiomyopathy (DCM) using a novel cardiac biological assist device created from engineered heart tissue (EHT).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback